|
1
|
Gaziano T, Reddy KS, Paccaud F, Horton S
and Chaturvedi V: Cardiovascular Disease. Disease Control
Priorities in Developing Countries (2nd). (Washington DC). World
Bank. 2006.
|
|
2
|
Bonow RO, Smaha LA, Smith SC Jr, Mensah GA
and Lenfant C: World Heart Day 2002. The international burden of
cardiovascular disease: Responding to the emerging global epidemic
Circulation. 106:1602–1605. 2002.
|
|
3
|
World Health Organization: Program Fact
Sheet no 310. The top 10 causes of death. http://www.who.int/mediacentre/factsheets/fs310/en/index.htmlAccessed.
January 6–2010
|
|
4
|
Fan L, Ma J, Chen YH and Chen XQ:
Antioxidant and antimicrobial phenolic compounds from Setaria
viridis. Chem Nat Comp. 3:433–437. 2014. View Article : Google Scholar
|
|
5
|
Nishida T, Shimokawa H, Oi K, Tatewaki H,
Uwatoku T, Abe K, Matsumoto Y, Kajihara N, Eto M, Matsuda T, et al:
Extracorporeal cardiac shock wave therapy ameliorates
ischemia-induced myocardial dysfunction in pigs in vivo.
Circulation. 110:3055–3061. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fukumoto Y, Ito A, Uwatoku T, Matoba T,
Kishi T, Tanaka H, Takeshita A, Sunagawa K and Shimokawa H:
Extracorporeal cardiac shock wave therapy ameliorates myocardial
ischemia in patients with severe coronary artery disease. Coron
Artery Dis. 17:63–70. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Uwatoku T, Ito K, Abe K, Qi K, Hizume T,
Sunagawa K and Shimokawa H: Extracorporeal cardiac shock wave
therapy improves left ventricular remodeling after acute myocardial
infarction in pigs. Coron Artery Dis. 18:397–404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimokawa H, Ito K, Fukumoto Y and Yasuda
S: Extracorporeal cardiac shock wave therapy for ischemic heart
disease. Shock Waves. 17:449–455. 2008. View Article : Google Scholar
|
|
9
|
Khattab AA, Brodersen B,
Schuermann-Kuchenbrandt D, Beurich H, Tölg R, Geist V, Schäfer T
and Richardt G: Extracorporeal cardiac shock wave therapy: First
experience in the everyday practice for treatment of chronic
refractory angina pectoris. Int J Cardiol. 121:84–85. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang P, Guo T, Wang W, Peng YZ, Wang Y,
Zhou P, Luo ZL, Cai HY, Zhao L and Yang HW: Randomized and
double-blind controlled clinical trial of extracorporeal cardiac
shock wave therapy for coronary heart disease. Heart Vessels.
28:284–291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ito Y, Ito K, Shiroto T, Tsuburaya R, Yi
GJ, Takeda M, Fukumoto Y, Yasuda S and Shimokawa H: Cardiac shock
wave therapy ameliorates left ventricular remodeling after
myocardial ischemia-reperfusion injury in pigs in vivo. Coron
Artery Dis. 21:304–311. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fu M, Sun CK, Lin YC, Wang CJ, Wu CJ, Ko
SF, Chua S, Sheu JJ, Chiang CH, Shao PL, et al: Extracorporeal
shock wave therapy reverses ischemia-related left ventricular
dysfunction and remodeling: Molecular-cellular and functional
assessment. PLoS One. 6:e243422011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schaufelberger M and Swedberg K: Is
6-minute walk test of value in congestive in heart failure? Am
Heart J. 136:371–372. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Spertus JA, Winder JA, Dewhurst TA, Deyo
RA, Prodzinski J, McDonell M and Fihn SD: Development and
evaluation of the Seattle Angina Questionnaire: A new functional
status measure for coronary artery disease. J AM Coll Cardiol.
25:333–341. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen XQ, Wang QQ, Li JM, Wang YQ, Zhang XZ
and Li K: Comparison of simultaneous distillation and extraction,
static headspace and headspace-solid phase microextraction coupled
with GC/MS to measure the flavour components of Tricholoma
matsutake. Asian J Chem. 25:6059–6063. 2013.
|
|
16
|
Nurzynska D, Di Meglio F, Castaldo C,
Arcucci A, Marlinghaus E, Russo S, Corrado B, de Santo L,
Baldascino F, Cotrufo M and Montagnani S: Shock waves activate in
vitro cultured progenitors and precursors of cardiac cell lineages
from the human heart. Ultrasound Med Biol. 34:334–342. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kikuchi Y, Ito K, Ito Y, Shiroto T,
Tsuburaya R, Aizawa K, Hao K, Fukumoto Y, Takahashi J, Takeda M, et
al: Double-blind and placebo-controlled study of the effectiveness
and safety of extracorporeal cardiac shock wave therapy for severe
angina pectoris. Circ J. 74:589–591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang CJ, Wang FS, Yang KD, Weng LH, Hsu
CC, Huang CS and Yang LC: Shock wave therapy induces
neovascularization at the tendon-bone junction. A study in rabbits.
J Orthop Res. 21:984–989. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Guo T, Cai HY, Ma TK, Tao SM, Sun
S, Chen MQ, Gu Y, Pang JH, Xiao JM, et al: Cardiac shock wave
therapy reduces angina and improves myocardial function in patients
with refractory coronary artery disease. Clin Cardiol. 33:693–699.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Guo T, Ma TK, Cai HY, Tao SM, Peng
YZ, Yang P, Chen MQ and Gu Y: A modified regimen of extracorporeal
cardiac shock wave therapy for treatment of coronary artery
disease. Cardiovasc Ultrasound. 10:352012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vasa M, Fichtlscherer S, Aicher A, Adler
K, Urbich C, Martin H, Zeiher AM and Dimmeler S: Number and
migratory activity of circulating endothelial progenitor cells
inversely correlate with risk factors for coronary artery disease.
Circ Res. 89:E1–E7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hill JM, Zalos G, Halcox JP, Schenke WH,
Waclawiw MA, Quyyumi AA and Finkel T: Circulating endothelial
progenitor cells, vascular function, and cardiovascular risk. N
Engl J Med. 348:593–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schmidt-Lucke C, Rössig L, Fichtlscherer
S, Vasa M, Britten M, Kämper U, Dimmeler S and Zeiher AM: Reduced
number of circulating endothelial progenitor cells predicts future
cardiovascular events: Proof of concept for the clinical importance
of endogenous vascular repair. Circulation. 111:2981–2987. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Igarashi J, Miyoshi M, Hashimoto T, Kubota
Y and Kosaka H: Statins induce S1P1 receptors and enhance
endothelial nitric oxide production in response to high-density
lipoproteins. Br J Pharmacol. 150:470–479. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thurston G, Rudge JS, Ioffe E, Zhou H,
Ross L, Croll SD, Glazer N, Holash J, McDonald DM and Yancopoulos
GD: Angiopoietin-1 protects the adult vasculature against plasma
leakage. Nat Med. 6:460–463. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Asahara T, Takahashi T, Masuda H, Kalka C,
Chen D, Iwaguro H, Inai Y, Silver M and Isner JM: VEGF contributes
to postnatal neovascularization by mobilizing bone marrow-derived
endothelial progenitor cells. EMBO J. 18:3964–3972. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gehling UM, Ergün S, Schumacher U, Wagener
C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, et
al: In vitro differentiation of endothelial cells from
AC133-positive progenitor cells. Blood. 95:3106–3112.
2000.PubMed/NCBI
|
|
28
|
Hattori K, Dias S, Heissig B, Hackett NR,
Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, et al:
Vascular endothelial growth factor and angiopoietin-1 stimulate
postnatal hematopoiesis by recruitment of vasculogenic and
hematopoietic stem cells. J Exp Med. 193:1005–1014. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carmeliet P, Ferreira V, Breier G,
Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A,
Harpal K, Eberhardt C, et al: Abnormal blood vessel development and
lethality in embryos lacking a single VEGF allele. Nature.
380:435–439. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ferrara N, Carver-Moore K, Chen H, Dowd M,
Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW:
Heterozygous embryonic lethality induced by targeted inactivation
of the VEGF gene. Nature. 380:439–442. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shalaby F, Rossant J, Yamaguchi TP,
Gertsenstein M, Wu XF, Breitman ML and Schuh AC: Failure of
blood-island formation and vasculogenesis in Flk-1-deficient mice.
Nature. 376:62–66. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gutersohn A, Caspari G and Erbel R:
Upregulation of Vascular endothelial growth factor m-RNA in Human
umbilical vascular endothelial cells via shock waves. Eur J Heart
Fail. 2(Suppl 1): 422000. View Article : Google Scholar
|
|
33
|
Kupatt C, Hinkel R, Pfosser A, El-Aouni C,
Wuchrer A, Fritz A, Globisch F, Thormann M, Horstkotte J, Lebherz
C, et al: Cotransfection of vascular endothelial growth factor-A
and platelet-derived growth factor-B via recombinant
adeno-associated virus resolves chronic ischemic malperfusion role
of vessel maturation. J Am Coll Cardiol. 56:414–422. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Urao N, Inomata H, Razvi M, Kim HW, Wary
K, McKinney R, Fukai T and Ushio-Fukai M: Role of nox2-based NADPH
oxidase in bone marrow and progenitor cell function involved in
neovascularization induced by hindlimb ischemia. Circ Res.
103:212–220. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lund T, Hermansen SE, Andreasen TV, Olsen
JO, Østerud B, Myrmel T and Ytrehus K: Shear stress regulates
inflammatory and thrombogenic gene transcripts in cultured human
endothelial progenitor cells. Thromb Haemost. 104:582–591. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kocher AA, Schuster MD, Bonaros N, Lietz
K, Xiang G, Martens TP, Kurlansky PA, Sondermeijer H, Witkowski P,
Boyle A, et al: Myocardial homing and neovascularization by human
bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J
Mol Cell Cardiol. 40:455–464. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
De Falco E, Porcelli D, Torella AR,
Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P,
Napolitano M, Capogrossi MC and Pesce M: SDF-1 involvement in
endothelial phenotype and ischemia-induced recruitment of bone
marrow progenitor cells. Blood. 104:3472–3482. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang PH, Chen YH, Wang CH, Chen JS, Tsai
HY, Lin FY, Lo WY, Wu TC, Sata M, Chen JW and Lin SJ: Matrix
metalloproteinase-9 is essential for ischemia-induced
neovascularization by modulating bone marrow-derived endothelial
progenitor cells. Arterioscler Thromb Vasc Biol. 29:1179–1184.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Valenzuela-Fernández A, Planchenault T,
Baleux F, Staropoli I, Le-Barillec K, Leduc D, Delaunay T, Lazarini
F, Virelizier JL, Chignard M, et al: Leukocyte elastase negatively
regulates Stromal cell-derived factor-1(SDF-1)/CXCR4 binding and
functions by amino-terminal processing of SDF-1 and CXCR4. J Biol
Chem. 277:15677–15689. 2002. View Article : Google Scholar : PubMed/NCBI
|
